Factor VIIIHalf-LifeHemophilia A
Dr. Michael Urban Callaghan, MD
NPI1285843672
- Part D claims, 2020
- 14
- Publications
- 93
- Clinical trials
- 2
- Industry payments
- $801,902
- Medical group
- 1
- Practice address
- 3901 Beaubien St, Detroit, MI 48201
- Practice phone
- Call (313) 745-5850
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
DMC Children's Hospital of Michigan
Detroit, Michigan
Find Dr. Callaghan's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Michael Urban Callaghan is a pediatric hematology and oncology physician in Detroit, Michigan
Dr. Callaghan practices at DMC Children's Hospital of Michigan in Detroit, Michigan.
Dr. Callaghan's NPI, 1285843672, was assigned on May 22, 2007. Dr. Callaghan graduated from Wayne State University School Of Medicine in 2003. Dr. Callaghan holds Michigan license 01-082493.
NPI and contact details
- NPI
- 1285843672NPI Registry (opens in a new tab)
- NPI enumeration date
- May 22, 2007
- NPI status
- Active
- Practice phone
- (313) 745-5850
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Medical school graduation
- 2003
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Practice Data
Dr. Michael Urban Callaghan practices at DMC Children's Hospital of Michigan in Detroit, Michigan
Dr. Callaghan's primary practice is DMC Children's Hospital of Michigan, at 3901 Beaubien St, Detroit, MI 48201 in Wayne County. The practice phone is (313) 745-5850.
- DMC Children's Hospital of Michigan3901 Beaubien St, Detroit, MI 48201 · Wayne CountyPhone(313) 745-5850
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Michael Urban Callaghan is affiliated with 1 site of care and 1 medical group
Dr. Callaghan's primary practice is DMC Children's Hospital of Michigan in Detroit, Michigan. The medical group on file is University Pediatricians.
DMC Children's Hospital of MichiganPrimary
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Michael Urban Callaghan's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Callaghan practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| DMC Children's Hospital of Michigan | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Callaghan practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Michael Urban Callaghan is one of 86 pediatric hematologys and oncology physicians in Michigan
Pediatric hematology-oncology is Dr. Callaghan's primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dr. Callaghan is board certified in pediatric hematology-oncology by the American Board of Pediatrics. Dmand AI has Dr. Callaghan's licenses on file in 2 states: Michigan and Ohio.
Specialties and state licenses
- Pediatric hematology and oncology, MichiganPrimary
- Ohio license
Pediatric hematologys and oncology physicians near Dr. Callaghan
Counts of pediatric hematologys and oncology physicians with a Dmand AI profile, by place and practice. Each opens the list.
86pediatric hematologys and oncology physicians in Michigan15pediatric hematologys and oncology physicians in Detroit
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Michael Urban Callaghan's patients have a median age of 13
Across all payers, Dmand AI patient panel data puts Dr. Callaghan's median patient age at 13, with 47% women.
Dr. Callaghan's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 13
Patient panel by sex, all payers
- Women47%
- Men53%
Source: Dmand AI Patient Panel Data
Dr. Michael Urban Callaghan wrote 14 Medicare Part D claims in 2020
In 2020, Dr. Callaghan wrote 14 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $156 in total drug cost. In 2019, CMS named 30 claims across 2 drugs.
Part D claims, 202014
Drugs named by CMS1
Total drug cost$156
Dr. Callaghan's most prescribed drugs by claims, 2020
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2019 to 2020
- 2019
- 2020
- Claims for drugs CMS names
- 2019: 302020: 1453%
Drugs named by CMS: 1 in 2020, 2 in 2019.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Find pediatric hematologys and oncology physicians like Dr. Callaghan by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Michael Urban Callaghan has 93 publications on record
Dmand AI links 93 papers to Dr. Callaghan, published from 2008 to 2023. 2018 was the busiest year, with 10. The most frequent topics are Hemophilia A, Anemia, Sickle Cell and Factor VIII. Dr. Callaghan has published most often in Haemophilia. Dr. Callaghan's most frequent co-authors are Madhvi Atul Rajpurkar, MD, Ahmar U. Zaidi, MD and Gallia Georgette Levy, MD, PhD.
Papers93
Years published2008 to 2023
Dr. Callaghan's papers by year, 2013 to 2023
Topics Dr. Callaghan writes about most
- Hemophilia A
- Anemia, Sickle Cell
- Factor VIII
- Hemorrhage
- Unfolded Protein Response
- Antibodies, Bispecific
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents
Dr. Callaghan's most frequent co-authors
- Madhvi Atul Rajpurkar, MD10 shared papers
- Ahmar U. Zaidi, MD10 shared papers
- Gallia Georgette Levy, MD, PhD9 shared papers
Recent publications by Dr. Callaghan
Expert Opin Investig Drugs
Hemophilia AHemorrhage
Pediatr Blood Cancer
Anemia, Sickle CellConsensus
See who Dr. Callaghan researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Callaghan works with, so you can find a warm path to the right pediatric hematologys and oncology physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Michael Urban Callaghan has worked on 2 clinical trials
Dmand AI links Dr. Callaghan to 2 clinical trials. Conditions studied include Anemia, Sickle Cell and Anemia, Hemolytic, Congenital.
Conditions in Dr. Callaghan's trials
- Anemia, Sickle Cell
- Anemia, Hemolytic, Congenital
Investigators on the most trials with Dr. Callaghan
- Robert Joseph Adams, MD1 shared trial
- Shayla Marie Bergmann, MD1 shared trial
- Carlton Dampier, MD1 shared trial
Recent clinical trials with Dr. Callaghan
Dose-Finding Study of SC411 in Children With Sickle Cell Disease (opens in a new tab)
Status unknownPhase 2
Anemia, Sickle CellAnemia, Hemolytic, CongenitalDocosahexaenoic Acid
Anemia, Sickle CellAnemia, Hemolytic, CongenitalVoxelotor
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Michael Urban Callaghan received $801,902 in industry payments from 2016 to 2024
CMS Open Payments shows 628 general payments to Dr. Callaghan from 19 drug and device companies from 2016 to 2024. Speaker and faculty fees make up the largest share, 41% of the total. Genentech, Inc. paid the most, $466,489. It also lists 26 research payments totaling $33,257 from 2020 to 2022.
General payments to Dr. Callaghan by program year, 2016 to 2024
General payments to Dr. Callaghan by kind, 2016 to 2024
$801.9Kin total
- Speaker and faculty fees$326,59941%
- Consulting fees$314,03439%
- Travel and lodging$123,80915%
- Grants$16,9742%
- Other$19,3202%
Companies that paid Dr. Callaghan the most, 2016 to 2024
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Michael Urban Callaghan graduated from Wayne State University School Of Medicine
Dr. Callaghan graduated from Wayne State University School Of Medicine in 2003.
- Medical school
- Board certified in pediatric hematology-oncology
- Board certified in pediatrics
Source: Dmand AI Professional Profile Data
Dr. Michael Urban Callaghan accepts plans from 8 insurance carriers
Dr. Callaghan is in network with 8 carriers, including Aetna, Health Alliance Plan and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.
- Aetna
- Health Alliance Plan
- Blue Cross Blue Shield of Michigan
- Priority Health
- United Healthcare
- Molina
- Blue Cross Blue Shield of Massachusetts
- McLaren Health Plan
Plan types Dr. Callaghan accepts, by number of carriers
- HMO7
- Medicare6
- POS5
- PPO5
- Medicaid3
- EPO2
Source: Dmand AI Insurance Network Data
Sources for Dr. Michael Urban Callaghan's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Michael Urban Callaghan
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Michael Urban Callaghan's NPI number?
Dr. Michael Urban Callaghan's NPI number is 1285843672. It was assigned on May 22, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Michael Urban Callaghan?
Dr. Michael Urban Callaghan is a pediatric hematology and oncology physician in Detroit, Michigan. The primary specialty in the NPI Registry is Pediatric Hematology & Oncology Physician (taxonomy code 2080P0207X).
Where does Dr. Michael Urban Callaghan practice?
Dr. Callaghan practices at 3901 Beaubien St, Detroit, MI 48201. Dr. Callaghan's primary practice is DMC Children's Hospital of Michigan in Detroit, Michigan.
What is Dr. Michael Urban Callaghan's office phone number?
The practice phone on file for Dr. Callaghan is (313) 745-5850.
What is Dr. Michael Urban Callaghan's medical license number?
Dr. Callaghan holds Michigan license 01-082493, one of the licenses on file in 2 states.
Which states has Dr. Michael Urban Callaghan been licensed in?
Dmand AI has state licenses on file for Dr. Callaghan in Michigan (2003 to 2026) and Ohio (2024 to 2026).
What medical group is Dr. Michael Urban Callaghan part of?
Dr. Callaghan is linked to University Pediatricians.
Is Dr. Michael Urban Callaghan board certified?
Yes. Dr. Callaghan is board certified in pediatric hematology-oncology by the American Board of Pediatrics.
Where did Dr. Michael Urban Callaghan go to medical school?
Dr. Callaghan graduated from Wayne State University School Of Medicine in 2003.
What drugs does Dr. Michael Urban Callaghan prescribe most?
In 2020 Medicare Part D data, Dr. Callaghan's most prescribed drugs by claims were Morphine Sulfate.
Show 5 more questionsShow fewer questions
Has Dr. Michael Urban Callaghan received payments from drug or device companies?
CMS Open Payments shows $801,902 in general payments to Dr. Callaghan from 19 companies from 2016 to 2024. The largest total came from Genentech, Inc.
How long has Dr. Michael Urban Callaghan been practicing?
Dr. Callaghan graduated from medical school in 2003, 23 years ago.
Does Dr. Michael Urban Callaghan do research?
Dmand AI links 93 publications to Dr. Callaghan, published from 2008 to 2023. Dr. Callaghan has worked on 2 clinical trials.
Who does Dr. Michael Urban Callaghan publish with?
Dr. Callaghan's most frequent co-authors are Madhvi Atul Rajpurkar, MD (10 shared papers), Ahmar U. Zaidi, MD (10 shared papers) and Gallia Georgette Levy, MD, PhD (9 shared papers).
What insurance does Dr. Michael Urban Callaghan accept?
Dr. Callaghan is in network with 8 carriers, including Aetna, Health Alliance Plan and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.
Selling to pediatric hematology-oncology practices?
See pediatric hematologys and oncology physicians in Michigan by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card